
To guide public health and vaccination strategies, researchers assessed a variety of factors regarding community-acquired pneumonia and its causes.
Pediatricians have so much faith in a drug for treating neonatal hyperbilirubinemia that even though it hasn't been approved by the Food & Drug Administration yet, they are recommending its use in their just-released guidelines.






